Literature DB >> 225018

L-alpha-alanine inhibition of pyruvate kinase from tumors of the human central nervous system.

C W van Veelen, H Verbiest, K J Zülch, B A van Ketel, M J van der Vlist, A M Vlug, G Rijksen, G E Staal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 225018

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

1.  Pyruvate kinase in human brain tumours. Its significance in the treatment of gliomas.

Authors:  C W van Veelen; H Verbiest; K J Zülch; B van Ketel; M J van der Vlist; A M Vlug; G Rijksen; G E Staal
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

2.  Pyruvate kinase inhibition in the diagnosis of gliomas with an intermediate degree of malignancy.

Authors:  H W Mostert; N J de Both; E H Rhijnsburger; W M Mackay; J H van den Berge; S Z Stefanko
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

3.  Glucose metabolism in human gliomas: correspondence of in situ and in vitro metabolic rates and altered energy metabolism.

Authors:  J Galarraga; D J Loreck; J F Graham; R L DeLaPaz; B H Smith; D Hallgren; C J Cummins
Journal:  Metab Brain Dis       Date:  1986-12       Impact factor: 3.584

4.  Discrimination between neuronal and glial cell tumours by pyruvate kinase electrophoresis.

Authors:  C W van Veelen; G Rijksen; G E Staal
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.